These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1387679)

  • 1. Down's syndrome: occurrence of ALZ-50 reactive neurons and the formation of senile plaques.
    Sparks DL; Hunsaker JC
    J Neurol Sci; 1992 May; 109(1):77-82. PubMed ID: 1387679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
    Ikeda S; Allsop D; Glenner GG
    Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
    Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The developmental and aging changes of Down's syndrome cell adhesion molecule expression in normal and Down's syndrome brains.
    Saito Y; Oka A; Mizuguchi M; Motonaga K; Mori Y; Becker LE; Arima K; Miyauchi J; Takashima S
    Acta Neuropathol; 2000 Dec; 100(6):654-64. PubMed ID: 11078217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
    Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
    Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early age-related progression of AD-like neuropathology in Down's syndrome.
    Sparks LD; Kryscio RJ; Hunsaker JC
    Am J Neurodegener Dis; 2013; 2(2):121-8. PubMed ID: 23844336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological studies on senile plaques in brains of patients with Down's syndrome.
    Fukuoka Y; Fujita T; Ito H
    Kobe J Med Sci; 1990 Dec; 36(5-6):153-71. PubMed ID: 1708000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of the morphology of senile plaques in Down's syndrome patients of different ages using immunocytochemical and lectin histochemical techniques.
    Mann DM; Brown A; Prinja D; Davies CA; Landon M; Masters CL; Beyreuthers K
    Neuropathol Appl Neurobiol; 1989; 15(4):317-29. PubMed ID: 2528701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical and lectin histochemical studies of plaques and tangles in Down's syndrome patients at different ages.
    Mann DM; Brown A; Wilks DP; Davies CA
    Prog Clin Biol Res; 1989; 317():849-56. PubMed ID: 2532371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alz-50 immunoreactive neuropil differentiates hippocampal complex subfields in Alzheimer's disease.
    Brady DR; Mufson EJ
    J Comp Neurol; 1991 Mar; 305(3):489-507. PubMed ID: 2037717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental immunohistochemistry of growth inhibitory factor in normal brains and brains of patients with Down syndrome.
    Arai Y; Uchida Y; Takashima S
    Pediatr Neurol; 1997 Sep; 17(2):134-8. PubMed ID: 9367293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-immunoreactive dystrophic neurites in Down's syndrome brains.
    Mattiace LA; Kress Y; Davies P; Ksiezak-Reding H; Yen SH; Dickson DW
    J Neuropathol Exp Neurol; 1991 Sep; 50(5):547-59. PubMed ID: 1654399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease.
    Murphy GM; Eng LF; Ellis WG; Perry G; Meissner LC; Tinklenberg JR
    Brain Res; 1990 Dec; 537(1-2):102-8. PubMed ID: 1707726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
    Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
    J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some morphometric observations on the brains of patients with Down's syndrome: their relationship to age and dementia.
    Mann DM; Royston MC; Ravindra CR
    J Neurol Sci; 1990 Nov; 99(2-3):153-64. PubMed ID: 2150858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced reactivity of Alz-50 antibody in brains of sudden infant death syndrome victims versus brains with lethal hypoxic/ischemic injury. Diagnostic significance after application of the ImmunoMax technique on routine paraffin material.
    Oehmichen M; Theuerkauf I; Bajanowski T; Merz H; Meissner C
    Acta Neuropathol; 1998 Mar; 95(3):280-6. PubMed ID: 9542593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome.
    Burger PC; Vogel FS
    Am J Pathol; 1973 Nov; 73(2):457-76. PubMed ID: 4271339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabotropic glutamate receptor 5 in Down's syndrome hippocampus during development: increased expression in astrocytes.
    Iyer AM; van Scheppingen J; Milenkovic I; Anink JJ; Lim D; Genazzani AA; Adle-Biassette H; Kovacs GG; Aronica E
    Curr Alzheimer Res; 2014; 11(7):694-705. PubMed ID: 25115540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.